Methode zur Lungenvolumenreduktion wirkt bei Frauen besser

Women with severe emphysema experience more significant and longer-lasting improvements than men following bronchoscopic thermal vapor ablation (BTVA), according to a study by researchers from Germany and Switzerland. Published in BMJ Open Respiratory Research, the data indicates women achieved gains in lung function and walking distance that were not statistically significant in men.

How does BTVA treat severe emphysema?

Bronchoscopic thermal vapor ablation involves the targeted delivery of heated water vapor into over-inflated areas of the lungs. This process triggers a local inflammatory reaction, according to the study authors.

The resulting inflammation causes the treated tissue to shrink. This shrinkage relieves the lungs, allowing them to function more effectively.

Did You Know? The research analyzed data from 231 individuals with severe emphysema, including 105 women and 126 men.

Why do women show better outcomes than men?

Women in the study saw lung function improve over the full 12-month observation period. Their lung over-inflation decreased after six and 12 months, and their quality of life increased at three, six, and 12 months, according to the researchers.

Additionally, women showed a significant increase in walking distance during the six-minute walk test at three and six months. The study authors suggest these results may be due to women exhibiting stronger inflammatory responses to the treatment, which is a key driver of the therapy’s success.

Expert Insight: Samantha Carter notes that the correlation between a patient’s inflammatory response and the treatment’s efficacy suggests that biological sex may be a critical variable in determining how a patient responds to thermal ablation.

How did the treatment affect men?

Men also benefited from the procedure, though the results were less comprehensive. Lung over-inflation decreased at three, six, and 12 months, and quality of life improved at three and six months, according to the data.

Coils zur Lungenvolumenreduktion bei fortgeschrittenem Lungenemphysem / COPD (Deutsch)

However, men did not maintain quality-of-life gains at the 12-month mark. The researchers found no statistically significant improvements in lung function or walking distance for male participants.

What happens next for this therapy?

The study authors suggest that differences in how men and women perceive and report improvements in quality of life may also contribute to the diverging data.

Further studies to better understand these gender-specific differences could lead to more individualized treatment plans. This may allow clinicians to tailor the ablation process to the specific biological responses of the patient.

Frequently Asked Questions

What is the primary mechanism of bronchoscopic thermal vapor ablation?
The procedure uses heated water vapor to create a local inflammatory reaction in over-inflated lung tissue, causing that tissue to shrink and relieve the lung.

In which areas did women outperform men in the study?
Women showed significant improvements in lung function over 12 months and increased walking distance at three and six months, while men showed no significant improvement in these two areas.

Why might women react more positively to BTVA?
Researchers suggest women may have stronger inflammatory responses to the treatment, or they may assess improvements in their quality of life differently than men.

How should medical providers balance gender-specific data when recommending lung treatments?